Cancer Registry of Norway
Oslo, 0379, Norway
Location status: Recruiting
Location contact
Giske Ursin
CONTACT
Ine Marie Larsson
CONTACT
NCT Number: NCT04480203
1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.
Interested in participating?
Request Info20 year–69 year
Female
Interventional
Not applicable
Oslo, 0379, Norway
Location status: Recruiting
Giske Ursin
CONTACT
Ine Marie Larsson
CONTACT
After completing the baseline HRQoL assessment, eligible breast cancer patients will be invited to participate in a randomized clinical trial.
Those who are willing will be randomly allocated to one of the following arms: a) Digital cognitive based stress management, b) Digital mindfulness based intervention or c) Control group.
The intervention is based on a revised version of the Stressproffen app, which was developed by the Oslo University Hospital (Lise Solberg Nes, Elin Børøsund and others).
Outcome measures include measures of perceived stress and HRQoL.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Invasive tumors must be:
Exclusion criteria
The participants will download an app (Stressproffen 2A) with cognitive based stress management.
Other names: CBSM
The participants will download an app (Stressproffen 2B) with mindfulness based intervention.
Other names: MBI
The participants will receive no app. (They will be able to download it after the end of the 3 year study).
Time frame: change from CABC baseline (week 0) to f-up week 21
Cohens perceived stress scale. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up week 21
RAND-36 questionnaire. Unit is summary score and module-specific scores
Time frame: change from CABC baseline (week 0) to f-up week 21
TOMCATS questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up week 21
PHQ-4 questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up week 21
Chalders' fatigue questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up week 21
Baer 2006 mindfulness questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up week 21
selected questions fro SUSSH questionnaire. Unit is summary score.
Time frame: From NBCR baseline to f-up week 20
EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.
Time frame: From NBCR baseline to f-up week 20
EORTC breast cancer questionnaire. Unit is summary score.
Time frame: From NBCR baseline to f-up week 20
neuropathy questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 15
Cohens perceived stress scale. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 15
RAND-36 questionnaire. Unit is summary score and module-specific scores
Time frame: change from CABC baseline (week 0) to f-up month 15
TOMCATS questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 15
Chalders' fatigue questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 15
Baer 2006 mindfulness questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 15
PHQ-4 questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 15
selected questions fro SUSSH questionnaire. Unit is summary score.
Time frame: status at f-up month 15
questions on employment. Whether employed and percentage
Time frame: change from CABC baseline (week 0) to f-up month 27
Cohens perceived stress scale. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 27
RAND-36 questionnaire. Unit is summary score and module-specific scores
Time frame: change from CABC baseline (week 0) to f-up month 27
TOMCATS questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 27
PHQ-4 questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 27
Chalders' fatigue questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 27
Baer 2006 mindfulness questionnaire. Unit is summary score.
Time frame: change from CABC baseline (week 0) to f-up month 27
selected questions fro SUSSH questionnaire. Unit is summary score.
Time frame: change from NBCR baseline to f-up month 27
EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.
Time frame: change from NBCR baseline to f-up month 27
EORTC breast cancer questionnaire. Unit is summary score.
Time frame: From NBCR baseline to f-up month 27
neuropathy questionnaire. Unit is summary score.
Contact information is provided by the study sponsor or research team.
Giske Ursin, MD, PhD
CONTACT
Ine M Larsson
CONTACT
Norwegian Institute of Public Health
Other Gov
Coping After Breast Cancer - CABC - Stressmestring Etter Brystkreft - SEB
Acronym: CABC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07253987
Breast Cancer Patients, Breast Diseases
Brno, Czechia
View Trial DetailsNCT06964802
Breast Cancer Patients, Breast Diseases
Istanbul, Uskudar, Turkey (Türkiye)
View Trial DetailsNCT07135960
Breast Cancer Patients
Portsmouth, United Kingdom
View Trial DetailsNCT07041762
Breast Cancer Patients
Cairo, Egypt
View Trial Details